StoxGud Sign in
50

Themis Medicare Limited

NSE: THEMISMED · Unclassified

₹101.25-0.38%06 Nov 2026

Ask the data

Instant answers about Themis Medicare Limited — computed from its filings, no language model
Market cap₹933 cr
Current price₹101.25
High / Low₹133 / ₹66
P/E23.3
P/B2.34
Book value₹43.3
ROE10.0%
ROCE9.8%
Debt / equity0.25
Dividend yield0.49%
EPS (TTM)₹4.34
Face value₹1

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin
showing latest 6 of 7 periods
FY18FY20FY21FY22FY23FY24FY26
Revenue211.7201.6230.7394.6354.3381.8342.2
EBITDA25.035.749.595.667.551.50.4
Operating margin11.8%17.7%21.5%24.2%19.0%13.5%0.1%
Interest11.912.912.78.89.69.410.7
Depreciation7.48.38.69.510.512.210.3
Profit before tax8.718.031.983.958.934.6-12.1
Tax0.12.15.622.415.69.90.8
Net profit11.324.835.772.956.943.51.1
EPS ₹12.2426.9738.8679.2261.834.730.12
Operating cash flow———34.416.114.5-3.3
Capex———20.328.818.44.9
Dividend paid———4.04.64.64.6
Total assets————514.0566.4597.9
Equity————339.4377.7398.6

Quarterly performance

last 27 quarters · ₹ crore
showing latest 8 of 27 periods
MAR '18JUN '19SEP '19DEC '19MAR '20JUN '20SEP '20DEC '20MAR '21JUN '21DEC '21MAR '22JUN '22SEP '22DEC '22MAR '23JUN '23SEP '23DEC '23MAR '24JUN '24SEP '24DEC '24SEP '25DEC '25MAR '26JUN '26
Revenue52.251.350.353.846.148.554.965.561.8112.594.979.894.491.088.880.196.7104.882.597.8123.0117.093.878.090.176.587.0
Operating profit9.77.55.49.313.412.39.715.212.240.517.314.420.421.315.310.521.712.48.19.329.217.18.5-3.19.83.8-52.4
Operating margin18.7%14.6%10.8%17.3%29.0%25.4%17.7%23.3%19.8%36.0%18.2%18.1%21.6%23.5%17.2%13.1%22.5%11.8%9.8%9.5%23.7%14.6%9.1%-4.0%10.9%4.9%-60.3%
Other income0.70.10.12.90.40.42.10.20.90.34.11.80.72.05.93.00.72.40.61.11.01.11.03.21.33.71.0
Interest2.83.23.33.03.43.03.72.93.12.72.11.92.32.42.22.72.52.02.72.22.42.42.82.82.82.73.0
Depreciation2.22.12.12.12.12.02.02.12.42.42.42.42.52.62.72.83.03.13.13.12.42.52.52.62.62.62.5
Profit before tax5.52.30.17.28.37.66.110.57.735.816.911.916.318.416.37.916.99.72.95.225.413.44.2-5.24.92.136.0
Tax0.8-0.2-0.5-0.33.12.00.42.01.29.14.84.44.74.84.21.94.32.60.82.16.73.51.10.20.30.214.0
Net profit4.75.21.70.07.37.88.111.88.131.212.49.917.417.813.28.418.211.37.46.624.70.00.5-3.610.18.924.6
EPS ₹5.105.621.8311.627.928.448.8512.808.7633.9313.5410.8118.9219.3314.479.1319.7712.300.800.722.681.550.06-0.391.100.962.67
Revenue YoY—————-5.5%9.1%21.8%33.8%132.0%44.9%29.2%-16.1%—-6.5%0.4%2.3%15.1%-7.1%22.1%27.3%11.7%13.7%-33.3%-3.9%——
Profit YoY—————50.2%383.9%—10.6%302.6%5.3%23.6%-44.2%—6.9%-15.5%4.5%-36.3%-44.3%-21.0%35.7%-100.0%-92.9%—1840.4%——

Earlier results (standalone, Sep '07 – Dec '17)

₹ crore · from BSE, before the NSE XBRL filings begin

Themis Medicare Limited reports consolidated figures above. Quarterly consolidated results only became mandatory in India in 2019, so the earlier history available is the standalone company only (excluding subsidiaries). It is shown separately so the two bases are never mixed.

Full years

showing latest 8 of 9 periods
FY09†FY10†FY11†FY12†FY13†FY14†FY15†FY16†FY17†
Revenue199.9212.5235.7137.9148.2171.7166.9202.9216.7
Operating profit3.928.219.7-16.39.218.710.931.431.9
Operating margin2.0%13.3%8.3%-11.8%6.2%10.9%6.5%15.5%14.7%
Other income6.04.25.62.33.24.012.52.72.8
Interest11.39.310.313.515.215.614.512.210.9
Depreciation5.15.25.15.15.86.07.37.56.8
Profit before tax-9.417.910.2-34.7-8.51.11.614.517.0
Tax1.0-0.80.10.0-0.4-0.4-0.5-0.5-0.5
Net profit-10.418.710.1-34.7-8.11.52.015.117.5

Quarters

showing latest 8 of 42 periods
SEP '07†DEC '07†MAR '08†JUN '08†SEP '08†DEC '08†MAR '09†JUN '09†SEP '09†DEC '09†MAR '10†JUN '10†SEP '10†DEC '10†MAR '11†JUN '11†SEP '11†DEC '11†MAR '12†JUN '12†SEP '12†DEC '12†MAR '13†JUN '13†SEP '13†DEC '13†MAR '14†JUN '14†SEP '14†DEC '14†MAR '15†JUN '15†SEP '15†DEC '15†MAR '16†JUN '16†SEP '16†DEC '16†MAR '17†JUN '17†SEP '17†DEC '17†
Revenue61.048.051.257.655.038.249.154.261.048.049.466.280.256.033.330.929.642.934.648.040.134.825.350.455.734.331.248.039.338.640.951.556.450.544.556.856.454.449.047.462.150.0
Operating profit7.44.32.73.54.6-0.8-3.35.811.57.53.47.611.54.7-4.1-5.6-11.60.9-0.12.55.8-0.00.95.29.21.62.75.75.9-5.14.47.29.58.46.38.011.06.36.60.69.55.2
Operating margin12.1%9.0%5.2%6.0%8.4%-2.2%-6.8%10.8%18.9%15.6%6.9%11.5%14.3%8.4%-12.4%-18.2%-39.1%2.2%-0.3%5.3%14.5%-0.0%3.4%10.3%16.6%4.7%8.6%11.8%15.0%-13.2%10.8%14.0%16.9%16.6%14.2%14.1%19.4%11.6%13.5%1.3%15.3%10.4%
Other income0.30.52.31.70.50.13.71.31.80.20.81.12.21.80.51.70.30.20.13.30.00.1-0.20.80.10.82.30.80.110.80.81.70.00.50.51.90.50.20.30.31.70.3
Interest2.22.02.42.62.82.43.52.52.32.12.52.72.42.52.73.33.72.53.94.54.32.83.74.04.23.73.73.54.03.63.33.13.03.03.12.82.82.62.73.03.42.6
Depreciation1.01.01.11.21.21.21.51.21.31.11.61.21.31.11.51.21.21.31.31.31.51.51.41.41.51.51.61.71.91.91.91.91.91.91.91.71.71.71.71.71.81.8
Profit before tax4.51.81.51.31.1-6.5-5.33.49.84.60.14.210.43.4-7.9-8.5-17.1-3.9-5.2-0.00.0-4.1-4.40.63.6-2.8-0.21.30.10.10.04.04.74.01.95.46.92.22.5-3.85.91.1
Tax0.60.1-0.40.10.00.10.80.00.3-0.4-0.70.2-0.20.00.00.1-0.10.1-0.2-0.1-0.1-0.1-0.1-0.10.00.0-0.3-0.10.00.0-0.30.00.00.0-0.5-0.1-0.1-0.1-0.1-0.1-0.4-0.2
Net profit3.91.61.91.21.1-6.5-6.13.49.55.00.84.110.63.4-7.9-8.6-17.0-3.9-5.10.10.1-4.0-4.30.73.6-2.80.11.40.10.10.44.04.74.02.45.57.12.32.6-3.76.31.4
EPS ₹4.872.022.321.451.33-8.14-7.564.2811.806.190.935.0413.134.24-9.83-10.71-21.17-4.87-6.310.080.17-4.99-5.350.864.45-3.480.071.670.120.160.464.745.484.722.806.107.832.582.92-4.076.951.47
Revenue YoY————-9.8%-20.5%-4.2%-6.0%10.9%25.7%0.6%22.2%31.5%16.7%-32.6%-53.4%-63.1%-23.5%4.1%55.5%35.8%-18.8%-26.9%5.1%38.8%-1.4%23.4%-4.7%-29.4%12.5%30.7%7.2%43.4%30.6%8.8%10.2%0.0%7.9%10.2%-16.5%10.0%-8.2%
Profit YoY————-72.7%-501.8%-425.1%193.2%787.9%——18.4%11.3%-31.3%-1154.7%-312.3%-261.2%-214.6%—————1050.0%2457.1%——104.3%-97.2%—550.0%185.1%4550.0%2764.3%512.8%36.8%52.0%-41.9%10.5%-167.1%-11.0%-42.1%

Returns & margins

trailing-twelve-month, per quarter
showing latest 8 of 17 periods
MAR '20JUN '20SEP '20DEC '20MAR '21JUN '21SEP '22DEC '22MAR '23JUN '23SEP '23DEC '23MAR '24JUN '24SEP '24DEC '24JUN '26
ROE——————18.1%18.4%16.7%17.0%14.0%12.4%11.5%13.2%9.4%7.7%10.0%
ROCE——————18.4%18.2%15.9%16.1%13.1%10.3%9.3%11.1%11.4%11.7%9.8%
Net margin7.0%8.4%11.4%16.2%15.5%20.1%16.0%16.5%16.0%16.2%13.8%12.4%11.4%12.3%9.2%7.4%12.1%
EBITDA margin17.7%20.4%22.0%23.5%21.5%26.4%20.4%20.2%19.0%19.3%16.2%14.5%13.5%14.4%15.1%14.9%-12.7%
Debt / equity——————0.240.240.270.270.260.260.250.250.200.200.25
Interest coverage2.402.843.233.493.515.858.328.167.157.076.364.774.705.675.855.944.38
Asset turnover——————0.770.760.690.690.680.660.670.720.700.720.55

Balance sheet

equity vs borrowings over time · ₹ crore
showing latest 6 of 7 periods
SEP '22MAR '23SEP '23MAR '24SEP '24SEP '25MAR '26
Share capital9.29.29.29.29.29.29.2
Other equity / reserves308.7330.2354.9368.5402.8370.8389.4
Total equity317.9339.4364.1377.7412.0380.0398.6
Borrowings75.692.094.695.881.595.6100.1
Current liabilities120.5139.1149.2154.6158.4173.9166.2
Non-current liabilities28.735.435.134.231.828.633.2
Total assets467.1514.0548.5566.4602.2582.5597.9
Property, plant & equipment143.0161.0165.0167.8173.3168.7166.4
Capital work-in-progress9.02.63.32.63.23.42.5
Investments66.30.379.988.999.396.4108.8
Inventories54.569.059.670.664.576.581.1
Receivables141.2145.0177.6177.9200.7173.4178.1
Cash & equivalents13.012.613.59.99.78.14.5

Cash flow

annual · ₹ crore · line = free cash flow
FY22FY23FY24FY26
Cash from operations34.416.114.5-3.3
Cash from investing-15.2-24.0-15.9-2.5
Cash from financing-17.60.1-1.13.8
Capex20.328.818.44.9
Free cash flow14.1-12.7-4.0-8.1
Dividends paid4.04.64.64.6

Where the assets sit

Mar '26 · ₹ crore
Fixed assets (PPE)
₹166.4 cr28%
CWIP
₹2.5 cr0%
Investments
₹108.8 cr18%
Inventories
₹81.1 cr14%
Receivables
₹178.1 cr30%
Cash & equivalents
₹4.5 cr1%
Other assets
₹56.4 cr9%

Peer comparison

largest in Unclassified · this company in bold
CompanyMarket cap ₹crPriceP/EP/BROE
Avantel Limited36,86,04,549138.69—1059360.680.0%
Ducol Organics And Colours Limited19,55,275120.00—20089.130.0%
Jio Platforms Limited12,57,1811,406.40—3.57—
SBI Funds Management Limited1,01,750499.55———
Tamilnadu Telecommunication Limited91,3149.93———
Manipal Health Enterprises Limited76,294646.70———
INDO-MIM Limited59,0421,219.50———
AvenuesAI Limited45,138129.25153.69.516.2%
Dhoot Transmission Limited32,7611,601.60—8.11—
3M India Limited31,07127,570.0053.817.5732.7%
Themis Medicare Limited933101.2523.32.3410.0%

StoxGud checklist: Neutral setup · 5/10

  • Price above 50-day average
  • Price above 200-day average
  • 50-day average above 200-day (uptrend)
  • RSI in healthy 40–70 zone
  • Positive 1-year return
  • Return on equity above 15%
  • Debt to equity below 1
  • Revenue growing year on year
  • Net profit margin above 10%
  • P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-12.3%
6 months+2.3%
1 year-19.0%
3Y CAGR-11.0%
5Y CAGR+0.6%
10Y CAGR+4.7%
50-day avg₹113.31
200-day avg₹100.81
RSI (14)43

FAQs

What is the share price of Themis Medicare Limited?

Themis Medicare Limited (THEMISMED) closed at ₹101.25 on NSE on 06 Nov 2026.

What is the market cap of Themis Medicare Limited?

₹933 crore at the latest close.

What is the P/E ratio of Themis Medicare Limited?

23.3, on trailing-twelve-month earnings from its filings.

How fast is Themis Medicare Limited growing?

Themis Medicare Limited: revenue has compounded at -4.6% a year over three years; net profit at -75.0% a year.

How profitable is Themis Medicare Limited?

On a trailing-twelve-month basis return on equity is 10.0%, return on capital employed 9.8%, operating margin -12.7%, net margin 12.1%.

How much debt does Themis Medicare Limited have?

Themis Medicare Limited is lightly geared: debt to equity is 0.25 with borrowings of ₹100 cr against cash of ₹5 cr (balance sheet of 2026-03-31). Operating profit covers interest 4.4 times.

Financials parsed from Themis Medicare Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from MAR '18, annual from FY18, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.